Case Challenge

Management of a 50-Year-Old Male Smoker With Advanced Non-Small-Cell Lung Cancer

Source: Targeted Therapies in the Treatment of Non-Small-Cell Lung Cancer

Management of a 50-Year-Old Male Smoker With Advanced Non-Small-Cell Lung Cancer


Faculty:

  • Alan B. Sandler, MD

CME CREDIT INFORMATION

Release Date: 02/07/07

Expiration Date: 02/06/08


Physicians: maximum of 0.75 AMA PRA Category 1 Credit(s)

Status: Please log in to view status



Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss the results of recent clinical studies of antiangiogenic agents combined with platinum-based chemotherapies in patients with advanced non-small-cell lung cancer
  • Describe the safety and efficacy of combining vascular endothelial growth factor and epidermal growth factor receptor inhibitors in the treatment of advanced non-small-cell lung cancer
  • Recall optimal dosing and frequency of bevacizumab for the treatment of non-small-cell lung cancer

Test your ability to make optimal treatment decisions using patient histories and diagnostic information and see the case unfold according to your choices. Compare your answers with your peers and our expert faculty’s recommendations, and then review the supporting data.

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Medical Education Collaborative and Clinical Care Options, LLC.

Educational grant provided by:

Educational grants support only the CME-certified components of this program.